Sienna Biopharmaceuticals, Inc.·4

Jun 4, 9:32 PM ET

Stroehmann Diane 4

4 · Sienna Biopharmaceuticals, Inc. · Filed Jun 4, 2018

Insider Transaction Report

Form 4
Period: 2018-06-01
Stroehmann Diane
See Remarks
Transactions
  • Award

    Stock Options (Right to buy)

    2018-06-01+48,72048,720 total
    Exercise: $15.08Exp: 2028-06-01Common Stock (48,720 underlying)
Holdings
  • Common Stock

    126,686
Footnotes (2)
  • [F1]Includes 1,962 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 31, 2018.
  • [F2]Twenty-Five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from June 1, 2018, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT